Stock Quote
Forest Laboratories, Inc. (FRX.N) (New York Stock Exchange)
$30.60
12:30pm EST
-1.61%
$31.10
$30.37
260,800
$30.74
$30.25
$31.14
$18.37
0.83
2,535,870
FRX.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Solomon, Howard | Chairman of the Board, Chief Executive Officer | 5,118,000 |
| Olanoff, Lawrence | President, Chief Operating Officer, Director | 4,177,250 |
| Perier, Francis | Chief Financial Officer, Senior Vice President - Finance | 2,191,230 |
Profile
Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products, which require a physician’s prescription. The Company’s products in the United States consist of branded ethical drug specialties marketed directly or detailed to... Full Description
Company Address
Forest Laboratories, Inc.
909 Third Avenue
New York NY 10022
P: +1212.4217850
F: +1212.7509152
909 Third Avenue
New York NY 10022
P: +1212.4217850
F: +1212.7509152
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Pfizer Inc. | $18.28 | -0.31 |
| Johnson & Johnson | $62.79 | -0.51 |
| GlaxoSmithKline plc | £1,279.00 | +7.00 |
| FRX.N | Industry | |
|---|---|---|
| P/E(TTM) | 12.90 | 3.66 |
| P/S(TTM) | 2.33 | 0.55 |
| ROI(TTM) | 16.20 | 1.88 |
| ROE(TTM) | 17.19 | 2.54 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.88 |
| EPS Est. (Current Year) | 3.44 |
| Total Revenue | $1,063.93M |
| Net Income | $186.66M |
| EPS | $0.61 |
